Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity.
Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity. Nat Biotechnol. 2013 Nov; 31(11):1047-52.